|
|
|
| Establishment of New Bone Tissue Engineering Three-Dimensional Complex in vitro |
| Maimaitiaili Abulikemu, Wang Tengfei, Tao Ying ,Wang Xiaoshuai ,Xu Leilei ,Song Xinghua* |
| Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China |
|
[1] World Health Organization.Global tuberculosis report 2015[EB/OL].http://www.tbonline.info/posts/2015/10/28/global\|tuberculosis\|report\|2015,2015\|12/2017\|05\|20.
[2] 全国第五次结核病流行病学抽样调查技术指导组.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508.
[3] Pigrau-serrallach C,Rodr Guez-padro D.Bone and joint tuberculosis[J].Eur Spine J,2013,22(4):556-566.
[4] Chang KC, Yew WW. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Update 2012[J]. Respirology, 2013, 18(1):8-21.
[5] 叶向阳,孙湘,贾会文,等.利福平/聚乳酸-聚羟基乙酸缓释微球的制备及特性[J].中国组织工程研究与临床康复,2011,15(51): 9608-9612.
[6] 刘江涛,王永清,夏侃,等.异烟肼聚乳酸缓释体的制备及体内外释药特性[J].中国脊柱脊髓杂志,2008,18(4):290-293.
[7] Arrigoni E, Girolamo LD, Giancamillo AD. Adipose-derived stem cells and rabbit bone regeneration: histomorphometric, immunohistochemical and mechanical characterization[J]. Journal of Orthopaedic Science, 2013, 18(2):331-339.
[8] 李海建,龙志成,张峥,等. HA/β-TCA复合材料与同种异体骨体外兔脂肪干细胞生物相容性的对比实验[J]. 新疆医科大学学报, 2015(8):949-953.
[9] Jarvis B, Lamb HM. Rifapentine[J]. Drugs, 1998, 56(4):607.
[10] Listed N. Rifapentine[J]. Tuberculosis, 2008, 88(2):155.
[11] 王丹,姜航航. 聚乳酸共聚物复合缓释药物的材料特征与实验应用[J]. 中国组织工程研究, 2013,17(8):1473-1480.
[12] 王丹,姜航航. 聚乳酸共聚物复合缓释药物的材料特征与实验应用[J]. 中国组织工程研究,2013,17(8):1473-1480. |
|
|
|
